Four Cases of Massive Infiltrating Congenital Cystic Hygroma Managed by Bleomycin Sclerosing Therapy |
Hyun Kwack1, Dong Wook Kim1, Kyung Woon No1, Jun Heo1, Sun Young Kim1, Young Pyo Jang1, Jung-Hwan Choi1, Chong Ku Yun1, Seong En Jung2, Gui Won Park2, Woo Gi Kim2, In Won Kim3, Kyung Mo Yeon3 |
1Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea 2Department of Pediatric Surgery, Seoul National University College of Medicine, Seoul, Korea 3Department of Radiology, Seoul National University College of Medicine, Seoul, Korea |
거대 침윤성 선천성 낭성수종의 Bleomycin 치험 4례 |
곽현1, 김동욱1, 조경운1, 허준1, 김순영1, 장영표1, 최중환1, 윤종구1, 정성은2, 박귀원2, 김우기2, 김인원3, 연경모3 |
1서울대학교 의과대학 소아외과학교실 2서울대학교 의과대학 소아외과학교실 3서울대학교 의과대학 진단방사선과학교실 |
|
|
Abstract |
Cystic hygroma is a true, benign, congenital multi-cystic tumor. It is thought to be arised from failure of the lymphatic system to communicate with the venous system. Frequently it occurs at birth, and it is found most commonly in the neck as painless and fluctuant mass.
For many years, surgical excision has been considered as the treatment of choice. However, excision of tumors, if incomplete, may readily be followed by wound infection and recurrence. Bleomycin given by local injection has drawn attention as an efficacious nonsurgical measure against residual or recurrent tumors.
In 4 cases we administered bleomycin to the patients after tapping of the cyst by aspiration with a puncture needle. There was no serious side effect with bleomycin injection and the size of the mass has become reduced in all 4 cases. |
Key Words:
Cystic hygroms, Bleomycin sclerosing therapy |
|